NIH-funded research R01 grant

ANT2 and mitochondrial dysfunction in COPD: how energy transport affects lung repair

Official title: The Role of Adenine Nucleotide Translocase in Mitochondrial Dysfunction Associated Senescence in Chronic Obstructive Pulmonary Disease (COPD)

Funded at University of Pittsburgh at Pittsburgh · NIH-11380637 · Data updated 2026-11-12

This project studies how a key mitochondrial transporter (ANT2) may drive aging-like cell changes and repair problems in the lungs of people with COPD.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Pittsburgh at Pittsburgh
NIH-funded
Lab location1 site (Pittsburgh, United States)
Project startAugust 1, 2023
Project endApril 30, 2028
Funding year2026
Award (this year)$620,112
NIH project number5R01HL168050-04
Project IDNIH-11380637 on NIH RePORTER

Who could benefit from this research

Could help

Adults with COPD or at risk due to cigarette smoke exposure, particularly those with interest in participating in cellular and tissue-based studies.

Less likely to help

People without COPD or those not contributing to cellular or tissue-based components may not experience direct benefits.

What this research studies

COPD damages lung repair cells, and this study explores whether a mitochondrial transporter called ANT2 worsens cell aging and epithelial repair in smokers’ lungs. Researchers will use human cell models and lung tissue to see how ANT2 loss or dysfunction changes mitochondrial function and senescence in alveolar type 2 cells. The goal is to uncover mechanisms that could lead to new therapies that restore proper energy balance and repair in COPD-affected lungs. By understanding ANT2's role, the team hopes to identify targets to slow disease progression and improve lung function for patients with COPD.

Why it matters

Potential benefit: If successful, findings could point to new strategies that protect lung repair cells and slow COPD progression.

How similar studies have gone: Previous work has linked ANT2 and mitochondrial function to cell fate, providing a foundation for this study, with potential for novel COPD-specific insights.

Where this research is happening

  • University of Pittsburgh at Pittsburgh
    Pittsburgh, United States
    Active

Researchers

  • Principal investigator: Kliment, Corrine R — University of Pittsburgh at Pittsburgh
  • Study coordinator: Kliment, Corrine R

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.